$DNDN Headlines Glimmer of hope for downtrodde
Post# of 102855
Posted On: 07/10/2014 11:18:05 AM
$DNDN Headlines
Glimmer of hope for downtrodden Dendreon with Provenge prospects 1:08 p.m. March 3, 2014 - Russ Britt
Dendreon jumps on winning European approval for prostate-cancer treatment 12:31 p.m. Sept. 17, 2013 - Russ Britt
Storm clouds getting darker for troubled Seattle biotech Dendreon 11:49 a.m. Aug. 23, 2013 - Russ Britt
Dendreon shares slump 16% on poor Provenge outlook 9:12 a.m. Aug. 9, 2013 - MarketWatch
In focus: Bears have another chance 9:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
As cancer drug sales struggle, Dendreon shares plunge 1:14 p.m. May 9, 2013 - Russ Britt
Analyst apologizes to clients for his call on Dendreon, stock climbs 1:00 p.m. March 7, 2013 - blogs.marketwatch.com
Four charts to watch 3:03 p.m. Feb. 7, 2013 - The Trading Deck
Synageva director bought shares for trust 2:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s movers; Best Buy has best day in 4 years 5:47 p.m. Jan. 11, 2013 - Sue Chang
Bernstein lifts Dendreon price target to $10 8:34 a.m. Jan. 11, 2013 - Greg Morcroft
Dendreon upgraded to outperform by Bernstein 8:34 a.m. Jan. 11, 2013 - Greg Morcroft
Analyst downgrades rain on Dendreon 3:43 p.m. July 31, 2012 - Val Brickates Kennedy
Dendreon down 21% on earnings, restructuring news 10:27 a.m. July 31, 2012 - Val Brickates Kennedy
Updates, advisories and surprises 8:31 p.m. July 30, 2012 - MarketWatch
Seagate shares drop on earnings, outlook 6:33 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to slash jobs amid tepid earnings 6:12 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares drop 18% after being unhalted 6:10 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to restructure, slash 600 jobs 4:31 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares halted for news pending 4:13 p.m. July 30, 2012 - Laura Mandaro
Stocks To Watch Today: NQ Mobile, CBS, Seadrill... 7:34 a.m. July 9, 2014 - Seeking Alpha
Morning Market Movers 8:37 a.m. July 8, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:04 a.m. July 8, 2014 - benzinga.com
New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May 2:43 p.m. July 7, 2014 - Seeking Alpha
What Does Dendreon Need To Succeed? 10:48 a.m. July 7, 2014 - Seeking Alpha
Big Pharma Needs Growth: Two Severely Undervalued Companies Ripe for a Takeover 3:04 p.m. July 5, 2014 - Wall St. Cheat Sheet
Long Or Short: Cancer Cures 10:12 a.m. June 26, 2014 - Seeking Alpha
Dendreon (DNDN) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape 9:58 a.m. June 26, 2014 - Zacks.com
Dendreon May Still Be In Play 10:51 a.m. June 24, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:07 a.m. June 24, 2014 - benzinga.com
Long Or Short - Cancer Cures 3:06 a.m. June 24, 2014 - Seeking Alpha
3 Terrific Reasons To Buy Dendreon 6:00 p.m. June 18, 2014 - Seeking Alpha
Dendreon: An Update On The Debt Situation 11:14 a.m. June 18, 2014 - Seeking Alpha
Dendreon's Dreaded Outlook 7:48 a.m. June 12, 2014 - Barrons.com
Dendreon CEO To Shorts: Bombs Away! 7:42 a.m. June 11, 2014 - Seeking Alpha
Dendreon's CEO Departs at Critical Juncture - Analyst Blog 5:20 p.m. June 10, 2014 - Zacks.com
Cantor Weighs In On Dendreon Leadership Change 9:50 a.m. June 10, 2014 - benzinga.com
Dendreon CEO Leaves: Buyout Or Bankruptcy? 6:42 p.m. June 9, 2014 - Seeking Alpha
Dendreon CEO Exits Ahead of Big Debt Payment 4:38 p.m. June 9, 2014 - TheStreet.com
Dendreon CEO stepping down; shares +2.3% AH 4:27 p.m. June 9, 2014 - Seeking Alpha
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. Today - PR Newswire - PRF
Dendreon Announces Leadership Transition 4:15 p.m. June 9, 2014 - BusinessWire - BZX
Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics 7:40 a.m. May 30, 2014 - PR Newswire - PRF
Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals 7:40 a.m. May 23, 2014 - PR Newswire - PRF
Critical Alerts For JC Penney, Vipshop, Dendreon, Clovis Oncology, and Smith & Wesson Released By InvestorsObserver 9:31 a.m. May 21, 2014 - PR Newswire - PRF
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Dendreon to Host Conference Call on May 8 to Announce First Quarter Financial Results 4:02 p.m. April 28, 2014 - BusinessWire - BZX
Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T) is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer 7:01 a.m. April 11, 2014 - BusinessWire - BZX
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus 10:46 a.m. March 24, 2014 - PR Newswire - PRF
Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors 8:01 a.m. March 18, 2014 - GlobeNewswire
Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array 2:13 p.m. March 5, 2014 - PR Newswire - PRF
Critical Alerts For Dendreon, Qualcomm, Urban Outfitters, LinkedIn, and Proto Labs Released By InvestorsObserver 10:31 a.m. March 4, 2014 - PR Newswire - PRF
Dendreon Announces Plans to Make PROVENGE® Commercially Available in Europe 8:32 a.m. March 3, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into DENDREON CORP. Regarding Possible Breaches of Fiduciary Duty 1:53 p.m. Feb. 25, 2014 - PR Newswire - PRF
Dendreon Announces Webcast Presentation at Cowen and Company Health Care Conference 5:01 p.m. Feb. 20, 2014 - BusinessWire - BZX
Dendreon to Host Conference Call on March 3 to Announce Fourth Quarter and Full Year 2013 Financial Results 5:01 p.m. Feb. 14, 2014 - BusinessWire - BZX
Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2014 Genitourinary Cancer Symposium (ASCO GU) 9:01 a.m. Jan. 30, 2014 - BusinessWire - BZX
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Pre-Market Pulse: Dendreon, Novartis AG, Stryker, and Repros Therapeutics 9:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
RBCC Opens Talks with Top Innovators at Major Biotech Conference 9:56 a.m. Jan. 14, 2014 - BusinessWire - BZX
Glimmer of hope for downtrodden Dendreon with Provenge prospects 1:08 p.m. March 3, 2014 - Russ Britt
Dendreon jumps on winning European approval for prostate-cancer treatment 12:31 p.m. Sept. 17, 2013 - Russ Britt
Storm clouds getting darker for troubled Seattle biotech Dendreon 11:49 a.m. Aug. 23, 2013 - Russ Britt
Dendreon shares slump 16% on poor Provenge outlook 9:12 a.m. Aug. 9, 2013 - MarketWatch
In focus: Bears have another chance 9:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
As cancer drug sales struggle, Dendreon shares plunge 1:14 p.m. May 9, 2013 - Russ Britt
Analyst apologizes to clients for his call on Dendreon, stock climbs 1:00 p.m. March 7, 2013 - blogs.marketwatch.com
Four charts to watch 3:03 p.m. Feb. 7, 2013 - The Trading Deck
Synageva director bought shares for trust 2:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s movers; Best Buy has best day in 4 years 5:47 p.m. Jan. 11, 2013 - Sue Chang
Bernstein lifts Dendreon price target to $10 8:34 a.m. Jan. 11, 2013 - Greg Morcroft
Dendreon upgraded to outperform by Bernstein 8:34 a.m. Jan. 11, 2013 - Greg Morcroft
Analyst downgrades rain on Dendreon 3:43 p.m. July 31, 2012 - Val Brickates Kennedy
Dendreon down 21% on earnings, restructuring news 10:27 a.m. July 31, 2012 - Val Brickates Kennedy
Updates, advisories and surprises 8:31 p.m. July 30, 2012 - MarketWatch
Seagate shares drop on earnings, outlook 6:33 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to slash jobs amid tepid earnings 6:12 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares drop 18% after being unhalted 6:10 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to restructure, slash 600 jobs 4:31 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares halted for news pending 4:13 p.m. July 30, 2012 - Laura Mandaro
Stocks To Watch Today: NQ Mobile, CBS, Seadrill... 7:34 a.m. July 9, 2014 - Seeking Alpha
Morning Market Movers 8:37 a.m. July 8, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:04 a.m. July 8, 2014 - benzinga.com
New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May 2:43 p.m. July 7, 2014 - Seeking Alpha
What Does Dendreon Need To Succeed? 10:48 a.m. July 7, 2014 - Seeking Alpha
Big Pharma Needs Growth: Two Severely Undervalued Companies Ripe for a Takeover 3:04 p.m. July 5, 2014 - Wall St. Cheat Sheet
Long Or Short: Cancer Cures 10:12 a.m. June 26, 2014 - Seeking Alpha
Dendreon (DNDN) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape 9:58 a.m. June 26, 2014 - Zacks.com
Dendreon May Still Be In Play 10:51 a.m. June 24, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:07 a.m. June 24, 2014 - benzinga.com
Long Or Short - Cancer Cures 3:06 a.m. June 24, 2014 - Seeking Alpha
3 Terrific Reasons To Buy Dendreon 6:00 p.m. June 18, 2014 - Seeking Alpha
Dendreon: An Update On The Debt Situation 11:14 a.m. June 18, 2014 - Seeking Alpha
Dendreon's Dreaded Outlook 7:48 a.m. June 12, 2014 - Barrons.com
Dendreon CEO To Shorts: Bombs Away! 7:42 a.m. June 11, 2014 - Seeking Alpha
Dendreon's CEO Departs at Critical Juncture - Analyst Blog 5:20 p.m. June 10, 2014 - Zacks.com
Cantor Weighs In On Dendreon Leadership Change 9:50 a.m. June 10, 2014 - benzinga.com
Dendreon CEO Leaves: Buyout Or Bankruptcy? 6:42 p.m. June 9, 2014 - Seeking Alpha
Dendreon CEO Exits Ahead of Big Debt Payment 4:38 p.m. June 9, 2014 - TheStreet.com
Dendreon CEO stepping down; shares +2.3% AH 4:27 p.m. June 9, 2014 - Seeking Alpha
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. Today - PR Newswire - PRF
Dendreon Announces Leadership Transition 4:15 p.m. June 9, 2014 - BusinessWire - BZX
Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics 7:40 a.m. May 30, 2014 - PR Newswire - PRF
Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals 7:40 a.m. May 23, 2014 - PR Newswire - PRF
Critical Alerts For JC Penney, Vipshop, Dendreon, Clovis Oncology, and Smith & Wesson Released By InvestorsObserver 9:31 a.m. May 21, 2014 - PR Newswire - PRF
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Dendreon to Host Conference Call on May 8 to Announce First Quarter Financial Results 4:02 p.m. April 28, 2014 - BusinessWire - BZX
Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T) is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer 7:01 a.m. April 11, 2014 - BusinessWire - BZX
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus 10:46 a.m. March 24, 2014 - PR Newswire - PRF
Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors 8:01 a.m. March 18, 2014 - GlobeNewswire
Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array 2:13 p.m. March 5, 2014 - PR Newswire - PRF
Critical Alerts For Dendreon, Qualcomm, Urban Outfitters, LinkedIn, and Proto Labs Released By InvestorsObserver 10:31 a.m. March 4, 2014 - PR Newswire - PRF
Dendreon Announces Plans to Make PROVENGE® Commercially Available in Europe 8:32 a.m. March 3, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into DENDREON CORP. Regarding Possible Breaches of Fiduciary Duty 1:53 p.m. Feb. 25, 2014 - PR Newswire - PRF
Dendreon Announces Webcast Presentation at Cowen and Company Health Care Conference 5:01 p.m. Feb. 20, 2014 - BusinessWire - BZX
Dendreon to Host Conference Call on March 3 to Announce Fourth Quarter and Full Year 2013 Financial Results 5:01 p.m. Feb. 14, 2014 - BusinessWire - BZX
Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2014 Genitourinary Cancer Symposium (ASCO GU) 9:01 a.m. Jan. 30, 2014 - BusinessWire - BZX
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Pre-Market Pulse: Dendreon, Novartis AG, Stryker, and Repros Therapeutics 9:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
RBCC Opens Talks with Top Innovators at Major Biotech Conference 9:56 a.m. Jan. 14, 2014 - BusinessWire - BZX
(0)
(0)